• EPA Restricts Chemical Sterilizer of Medical Equipment

    The Environmental Protection Agency (EPA) announced new limits on a gas widely used to sterilize medical devices called ethylene oxide (EO), as a suspected carcinogen, on March 14. The agency first proposed new restrictions in 2023, recommending an 80 percent reduction in the use of the chemical. The new standards seek a reduction closer to…


  • Justices Appear Skeptical of COVID Censorship Case, Media Reports

    U.S. Supreme Court justices offered skeptical feedback in Murthy v. Missouri, a landmark case that is testing the limits of the federal government’s power to control information during a public health emergency, during oral arguments on March 22, according to many news reports. The case, formerly known as Missouri v. Biden, was brought by New…


  • Amicus Briefs Reveal Censorship Supporters – Commentary

    By the Brownstone Institute The convergence of state and corporate power has spawned unexpected bedfellows as Stanford University, the CATO Institute, and New York State Attorney General Letitia James have joined forces to support the censorship regime in Murthy v. Missouri. The David and Goliath dynamic of the case, which had oral arguments before the Supreme…


  • Health Authorities Made ‘Catastrophic Errors’ during COVID-19–Report

    Health Authorities Made ‘Catastrophic Errors’ during COVID-19–Report

    “Lockdowns, school closures, and other mandates were catastrophic errors, pushed with remarkable fervor by public health authorities at all levels,” concludes a report on the government’s response to the COVID-19 pandemic. The report, titled “COVID Lessons Learned: Retrospective After Four Years,” by Scott W. Atlas, M.D., Steve H. Hanke, Ph.D., Philip G. Kerpen, and Casey…


  • FDA Authority Under Scrutiny in Abortion Pill Case

    FDA Authority Under Scrutiny in Abortion Pill Case

    The U.S. Supreme Court heard arguments challenging the Food and Drug Administration’s (FDA) regulation of mifepristone, the first pill pregnant women take in inducing chemical abortions. The case, Food and Drug Administration v. Alliance for Hippocratic Medicine questions the legality of the FDA’s removal of basic patient safeguards for mifepristone since it was first approved…


  • Becerra Grilled on Putting Politics Before Health Policy

    Health and Human Services Secretary Xavier Becerra defended a wide range of White House health policies during a hearing of the House Ways and Means Committee, on March 21. From what GOP committee members said was the administration’s flawed implementation of a bipartisan law to end surprise billing by hospitals to the White House’s proposed…


  • Biden Administration Limits Short-Term Health Insurance to 90 Days

    Biden Administration Limits Short-Term Health Insurance to 90 Days

    Uninsured individuals will no longer be allowed to purchase short-term limited-duration insurance (STLDI) with a term of more than 90 days, plus a one-month renewal option, beginning September 1, 2024, under a rule issued by the Centers for Medicare and Medicaid Services (CMS). The new rule is likely to face legal challenges similar to what…


  • Short Term Health Plans Plus Indemnity Plans Offer Huge Savings – Commentary

    Indemnity Insurance is on the Block We would have very few public policy problems if we followed one of my rules for rational public policy: let the markets handle all the problems markets can solve; turn to government only to meet needs that competitive markets cannot or do not meet. In the first four years…


  • Medical Debt Forgiveness Advancing

    Americans owe at least $220 billion in medical debt, according to a KFF analysis of government survey data, and there is growing support to relieve patients of this financial burden. About 14 million people, or 6 percent of the adult population of the United States, are facing medical bills of more than $1,000, and three…


  • Researchers Study Repurposing Old Drugs to Treat Cancer

    A team of U.S. clinicians has launched a first-of-its-kind observational study on how repurposed drugs with expired patents, such as ivermectin, might help in treating cancer. The study, led by the Frontline COVID-19 Critical Care Alliance (FLCCC), began in February and is examining five-year survival rates for several types of cancers. Five hundred patients nationwide…


Latest Issue – September 2025

2025 Archived Editions: Jan, Feb, Mar, Apr, May, Jun, Aug

2024 Archived Editions: JanFebMarAprMayJune Aug, Sept, Oct, Nov

2023 Archived Editions: JanFebMarAprMayJunAugSepOctNov 

2022 Archived Editions: JanFebMarAprMayJulyAugSeptOctNov

2021 Archived Editions: JanFebMarAprMayJuneJulyAugSeptOctNov

2020 Archived Editions: JanMarAprJunJulAugSepOctNovDec

For back issues and articles published before January 2020, click here.